Clinical Trial: A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890299) titled 'A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions' on March 17.

Brief Summary: The purpose of this clinical study is to evaluate the pharmacokinetics and safety between single oral administration of BR3006 and co-administration of BR3006A, BR3006B and BR3006C in healthy adult volunteers under fed conditions

Study Start Date: Dec. 05, 2024

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: BR3006

One tablet administered alone

DRUG: BR3006A

One tablet adm...